| __timestamp | Arrowhead Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 13673000 |
| Thursday, January 1, 2015 | 57410147 | 14358000 |
| Friday, January 1, 2016 | 41454452 | 12203000 |
| Sunday, January 1, 2017 | 31690298 | 18125000 |
| Monday, January 1, 2018 | 52968505 | 17071000 |
| Tuesday, January 1, 2019 | 81048686 | 20018000 |
| Wednesday, January 1, 2020 | 128874979 | 32788000 |
| Friday, January 1, 2021 | 206342000 | 44966000 |
| Saturday, January 1, 2022 | 297307000 | 311681000 |
| Sunday, January 1, 2023 | 353188000 | 77707000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Lantheus Holdings, Inc. have demonstrated contrasting approaches to R&D investment.
Since 2014, Arrowhead Pharmaceuticals has consistently increased its R&D budget, culminating in a staggering 2,100% growth by 2023. This upward trajectory underscores the company's dedication to pioneering advancements in RNA interference therapeutics.
Conversely, Lantheus Holdings has shown a more conservative R&D spending pattern, with a notable peak in 2022. This strategic allocation reflects its focus on enhancing diagnostic imaging solutions.
While Arrowhead's R&D expenses surged, Lantheus's spending remained more stable, highlighting diverse strategies in the biotech sector. Missing data for 2024 suggests potential shifts in future investments.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.